News

A simple, widely available blood test may help flag people with diffuse systemic sclerosis (SSc) who are more likely to have interstitial lung disease (ILD), a serious complication marked by inflammation and scarring in the lungs, a study in Turkey found. Patients with ILD had a higher erythrocyte sedimentation rate (ESR),…

Nearly half of people with systemic sclerosis (SSc) surveyed in Australia had considered using facial cosmetic therapies, while nearly one in 4 had used at least one such treatment, a study found. Treatments were mainly considered or used to address SSc-related facial changes, and patients reported perceived improvement with nearly…

The U.S. Food and Drug Administration (FDA) has granted fast track designation to treprostinil, an inhaled therapy to treat Raynaud’s phenomenon — a cold, numb, or prickly sensation in the fingers and toes — associated with systemic sclerosis (SSc-RP). The medication, approved under the brand name Yutrepia for the…

Oral treatment with vitamin B3 for a couple of weeks may reduce abnormalities in tiny blood vessels of people with scleroderma who have Raynaud’s phenomenon, a small study suggests. After two weeks of supplementation, participants showed more normal and fewer giant blood vessels under the fingernails, although these…

John Stamos, the Emmy-nominated actor and producer known for his role on “Full House,” will receive the Bob Saget Legacy Award. The Scleroderma Research Foundation (SRF) gives this award to individuals who have used their voices to raise awareness and support research for scleroderma. Stamos will be honored at…

Treatment guidelines for scleroderma (SSc) have evolved since the turn of the century with advances in scientific understanding and the advent of new therapies. In line with these evolving guidelines, patterns of therapies prescribed to people with SSc have shifted markedly since 2000, according to a new analysis from…

Blood levels of a protein called KL-6 may help identify people with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who are at greater risk of short-term lung function decline, according to a new analysis of data from a Phase 3 clinical trial. Among participants who received a placebo in the…

People with scleroderma (SSc) who don’t show the so-called scleroderma pattern, a common diagnostic finding of small blood vessel damage associated with the condition, may experience a milder course of the disease, an Italian study suggests. About 5% of study participants didn’t show this characteristic pattern at the time…

Scientists at Northwestern University have developed a wireless sensor that may help monitor skin stiffness in conditions such as scleroderma from home. “The great thing about the sensor is it’s small, the potential for home use is tremendous, and for patients who know that they are at risk and…

People living with scleroderma are being invited to take part in a new survey designed to better understand how the chronic autoimmune disease affects their daily lives. The findings may help guide future research and, ultimately, improve patient care. The Scleroderma Health and Resources Survey, launched by the…